OPEN END-TURBO-OPTIONSSCHEIN - AMGEN | Real-time Boerse Frankfurt Warrants 03:21:25 2024-06-04 am EDT | ||
| 0.74 EUR | -1.33% |
|
| Current month | -5.06% | ||
| 1 month | -1.32% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-04 | 0.74 | -1.33% |
| 24-06-03 | 0.75 | -5.06% |
| 24-05-31 | 0.79 | -1.25% |
| 24-05-30 | 0.8 | -6.98% |
| 24-05-29 | 0.86 | +3.61% |
Real-time Boerse Frankfurt Warrants
Last update June 04, 2024 at 03:21 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | HSBC |
| WKN | HS41XD |
| ISIN | DE000HS41XD2 |
| Date issued | 2024-01-04 |
| Strike | 389 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.86 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.21 € |
|---|---|
| Lowest since issue | 0.6 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
307.4
USD
Average target price
316.3
USD
Spread / Average Target
+2.88%
- Stock Market
- Certificates
- Certificat
